Breast cancer research and the European Union Clinical Trials Directive
Running clinical trials in the commercial sector has always been associated with a certain amount of bureaucracy due to the stringent requirements needed to bring a new drug onto the market. Noncommercial trials have largely been performed outside these requirements. New legislation brought about as...
Uloženo v:
| Vydáno v: | Breast Cancer Res |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2004
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC468644/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15217484/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/bcr800 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|